Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA172382,R01CA236780,R01CA261995,R01CA249279,R50CA251961
Congressionally Directed Medical Research Programs
Grant: W81XWH2010137
Congressionally Directed Medical Research Programs
Grant: W81XWH-22-1-0082
National Institutes of Health
Grant: 1R01CA249279-01A1
Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer
National Institutes of Health
Grant: 5R50CA251961-02
Translational science specialist in genitourinary cancers
National Institutes of Health
Grant: 5R01CA236780-06
Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer
National Institutes of Health
Grant: 1R01CA172382-01
Elucidating a novel molecular biomarker for castration-resistant prostate cancer
National Institutes of Health
Grant: 5R01CA261995-05
CYP17A1-independent androgen synthesis and prostate cancer resistance to next-generation hormonal therapy
European Commission
Grant: 236780
Identity questions. Measuring openness and closure in European Societies.
NCI NIH HHS
Grant: R50 CA251961
NCI NIH HHS
Grant: R01 CA261995
NCI NIH HHS
Grant: R01 CA236780
NCI NIH HHS
Grant: R01 CA249279
NCI NIH HHS
Grant: R01 CA172382
FWCI
0.66
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals